ZNF516 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.889000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.784400E-01
Normal-vs-Stage2
2.146000E-01
Normal-vs-Stage3
7.067800E-02
Normal-vs-Stage4
4.922800E-01
Stage1-vs-Stage2
2.440400E-01
Stage1-vs-Stage3
7.806000E-02
Stage1-vs-Stage4
4.326200E-01
Stage2-vs-Stage3
1.70989999999094E-05
Stage2-vs-Stage4
7.561800E-01
Stage3-vs-Stage4
2.272800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.128000E-01
Normal-vs-AfricanAmerican
6.312600E-01
Normal-vs-Asian
1.399440E-01
Caucasian-vs-AfricanAmerican
8.779200E-01
Caucasian-vs-Asian
3.064600E-01
AfricanAmerican-vs-Asian
2.765600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.239600E-01
Normal-vs-Female
5.463600E-01
Male-vs-Female
9.338600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.290600E-01
Normal-vs-Age(41-60Yrs)
6.936200E-01
Normal-vs-Age(61-80Yrs)
5.657800E-01
Normal-vs-Age(81-100Yrs)
1.029630E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.529000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.962610E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.662800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.181750E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.479700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.985000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.263380E-01
Normal-vs-Daily Drinker
8.982100E-02
Normal-vs-Weekly Drinker
1.508800E-01
Normal-vs-Occasional Drinker
8.343600E-01
Normal-vs-Social Drinker
9.806200E-01
Non Drinker-vs-Daily Drinker
8.064000E-01
Non Drinker-vs-Weekly Drinker
8.991200E-01
Non Drinker-vs-Occasional Drinker
3.929800E-02
Non Drinker-vs-Social Drinker
4.102300E-02
Daily Drinker-vs-Weekly Drinker
9.398400E-01
Daily Drinker-vs-Occasional Drinker
3.134200E-02
Daily Drinker-vs-Social Drinker
3.148100E-02
Weekly Drinker-vs-Occasional Drinker
4.385900E-02
Weekly Drinker-vs-Social Drinker
5.273700E-02
Occasional Drinker-vs-Social Drinker
7.089600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.786400E-01
Normal-vs-Grade 2
9.862800E-03
Normal-vs-Grade 3
2.562300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.129400E-01
Grade 1-vs-Grade 3
3.563200E-01
Grade 1-vs-Grade 4
2.786400E-01
Grade 2-vs-Grade 3
2.480800E-01
Grade 2-vs-Grade 4
9.862800E-03
Grade 3-vs-Grade 4
2.562300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.747000E-01
Normal-vs-NonDiabetic
6.746200E-01
Diabetic-vs-NonDiabetic
2.932600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.637400E-01
Normal-vs-NoPancreatitis
6.487200E-01
Pancreatitis-vs-NoPancreatitis
5.968200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.607600E-01
Normal-vs-N1
2.203600E-01
N0-vs-N1
2.661000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.202250E-01
Normal-vs-TP53-NonMutant
9.834400E-01
TP53-Mutant-vs-TP53-NonMutant
6.995600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
